Anticancer activities of trichostatin A on malignant lymphoid cells

Abstract

The anticancer activity of trichostain A (TSA) on human B cell non-Hodgkin’s lymphoma and its mechanism were explored. The effect of TSA on the growth of Raji cells and normal peripheral blood mononuclear cells (NPBMNC) was studied by MTT assay. The effect of TSA on the apoptosis of Raji cells and NPBMNC was studied by flow cytometry and TDT-mediated dUTP nick end labeling (TUNEL). The effect of TSA on the cell cycle of Raji cells was studied by propidium iodide method. The results showed that TSA potently inhibited proliferation of Raji cells at microgram concentrations and induced apoptosis of Raji cells in a time-and concentration-dependent manner. Treatment with TSA induced accumulation of cells in G₀/G₁ or G₂/M and a concomitant decrease of cell population in S phase. However, NPBMNC was less sensitive to the cytotoxic effect of TSA than Raji cells. It was concluded that TSA may inhibit the proliferation of Raji cells by regulating the cell cycle and inducing the cell apoptosis. Moreover, TSA demonstrates low toxicity in NPBMNC but selectively induces apoptosis of Raji cells.

Keywords

Trichostatin A / Raji cell / Apoptosis / Cell cycle / Cytotoxicity

References

[1] CressW. D., SteoE.. Histone deacetylase, transcriptional control and cancer. J Cell Physiol, 2000, 184: 1-16

[2] ChenW. K., ChenY.. Histone acetylation: new target for leukemia treatment. Clin J Hematol (Chinese), 2002, 15: 233-234

[3] FinninM. S., DonigianJ. R., CohenA., et al.. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature, 1999, 401: 188-193

[4] WangZ. M., HuJ., ZhouD., et al.. Trichostatin A inhibits proliferation and induces expression of P21^WAF and P27 in human brain tumor cell lines. Chin J Cancer (Chinese), 2002, 21: 1100-1105

[5] HeroldC., GanslmayerM., OckerM., et al.. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol, 2002, 36: 233-240

[6] MosmannT.. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65: 55-63

[7] ParkW. H., JungC. W., ParkJ. O., et al.. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int J Oncol, 2003, 22: 1129-1134

[8] MedinaV., EdmondsB., YoungG. P., et al.. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitor of histone deacetylase): dependence on protein synthesis and synergy with a mitochodrial/cytochrome c-dependent pathway. Cancer Res, 1997, 57: 3697-3707

[9] MurataM., TowatariM., KosugiH., et al.. Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells. Jpn J Cancer Res, 2000, 91: 1154-1160

[10] OwaT., YoshinoH., YoshimatsuK., et al.. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem, 2001, 8: 1487-1503

[11] HuaangL., PardeeA. B.. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med, 2000, 6: 849-866

[12] SowaY., SakaiT.. Butyrate as a model for “gene-regulating chemoprevention and chemotherapy”. Biofactors, 2000, 12: 283-287

[13] MunsterP. N., Troso-SandovalT., RosenN., et al.. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res, 2001, 61(23): 8492-8497

[14] HoshikawaY., KwonH. J., YoshidaM., et al.. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res, 1994, 214: 189-197

[15] VigushinD. M., AliS., PaceP. E., et al.. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res, 2001, 7(4): 971-976